These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6875813)

  • 1. Some considerations on the estimation of steady state apparent volume of distribution and the relationships between volume terms.
    Collier PS
    J Pharmacokinet Biopharm; 1983 Feb; 11(1):93-105. PubMed ID: 6875813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of absolute bioavailability assuming steady state apparent volume of distribution remains constant.
    Collier PS; Riegelman S
    J Pharmacokinet Biopharm; 1983 Apr; 11(2):205-14. PubMed ID: 6886975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of statistical moments and steady-state volume of distribution for a drug given by intravenous infusion.
    Chan KK; Gibaldi M
    J Pharmacokinet Biopharm; 1982 Oct; 10(5):551-8. PubMed ID: 7166738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical comparison between volume of distribution (V) and volume of distribution at steady-state (Vss) utilizing model-independent approach.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 Mar; 25(2):99-101. PubMed ID: 14872558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation and estimates of mean residence time with statistical moment theory.
    Kasuya Y; Hirayama H; Kubota N; Pang KS
    Biopharm Drug Dispos; 1987; 8(3):223-34. PubMed ID: 3593900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of ratios of different volumes of distribution in pharmacokinetics.
    Wagner JG
    Biopharm Drug Dispos; 1983; 4(3):263-70. PubMed ID: 6626701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The connection between the steady state (Vss) and terminal (Vbeta) volumes of distribution in linear pharmacokinetics and the general proof that Vbeta >/= Vss.
    Berezhkovskiy LM
    J Pharm Sci; 2007 Jun; 96(6):1638-52. PubMed ID: 17117429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The physiological significance of total body clearance in pharmacokinetic studies.
    Chiou WL
    J Clin Hosp Pharm; 1982 Mar; 7(1):25-30. PubMed ID: 7096575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid, universal TI-59 model-independent pharmacokinetic analysis program based on statistical moment theory.
    Reitberg DP; Smith IL; Love SJ; Lewin HM; Schentag JJ
    Drug Intell Clin Pharm; 1985 Feb; 19(2):125-34. PubMed ID: 3838276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state distribution volume in physiologic multi-organ systems.
    Weiss M
    Biopharm Drug Dispos; 1983; 4(2):151-6. PubMed ID: 6882883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of queueing theory to pharmacokinetics.
    Brill PH; Moon RE
    J Pharm Sci; 1980 May; 69(5):558-60. PubMed ID: 7381743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution.
    Jones RD; Jones HM; Rowland M; Gibson CR; Yates JW; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4074-89. PubMed ID: 21452299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic parameters: which are necessary to define a drug substance?
    Benet LZ
    Eur J Respir Dis Suppl; 1984; 134():45-61. PubMed ID: 6586486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple integrated method for drug and derived metabolite kinetics. An application of the statistical moment theory.
    Chan KK
    Drug Metab Dispos; 1982; 10(5):474-9. PubMed ID: 6183086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.
    Ye M; Nagar S; Korzekwa K
    Biopharm Drug Dispos; 2016 Apr; 37(3):123-41. PubMed ID: 26531057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the possibility of the secondary peaks of iv bolus drug plasma concentration time curve by the model that directly takes into account the transit time through the organ.
    Berezhkovskiy LM
    J Pharm Sci; 2009 Nov; 98(11):4376-90. PubMed ID: 19340884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution Clearance: Significance and Underlying Mechanisms.
    Weiss M
    Pharm Res; 2024 Jul; 41(7):1391-1400. PubMed ID: 38981900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The determination of mean residence time using statistical moments: is it correct?
    Chanter DO
    J Pharmacokinet Biopharm; 1985 Feb; 13(1):93-100. PubMed ID: 4020624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial slope technique for estimation of the apparent volume of distribution during constant-rate intravenous infusion.
    Cocchetto JF; Cocchetto DM; Bjornsson TD; Bergan T
    J Pharm Sci; 1984 Jan; 73(1):58-62. PubMed ID: 6694084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.